FIELD: medicine.
SUBSTANCE: invention refers to medicine. The method of pharmacological correction of extremity ischemia by mixed solutions of homoeopathic dilutions in an experimental laboratory animal suffering experimental extremity ischemia, consists in the intragastric introduction of the mixed solutions of homoeopathic dilutions of monoclonal VEGF -C12, C30, C200 antibodies 4.5 ml/kg (9 ml/kg/day) to the laboratory animals twice a day for 28 days following ischemia simulation.
EFFECT: method provides clinical effectiveness in ischemia.
1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PHARMACOLOGICAL CORRECTION OF EXTREMITY ISCHEMIA | 2011 |
|
RU2466463C2 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIBODIES | 2011 |
|
RU2526151C2 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION | 2011 |
|
RU2526149C2 |
| THERAPEUTIC AGENT FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2500424C2 |
| MEDICINAL AGENT AND METHOD OF REGULATION OF CARBOHYDRATE AND LIPID METABOLISM | 2001 |
|
RU2199345C1 |
| THERAPEUTIC AGENT FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2543331C2 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF INTERLEUKIN-1 ANTIBODIES | 2011 |
|
RU2526150C2 |
| MEDICATION FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION | 2011 |
|
RU2536228C2 |
| THERAPEUTIC AGENT FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2543332C2 |
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2541166C2 |
